Skip to main content
SpringerLink
Log in

Experimentelle Therapie und somatische Gentherapie von Krebs

  • Chapter
Book cover Medizinische Therapie 2005|2006

  • 59 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anderson WF (1998) Human gene therapy. Nature 392: 25–30

    Article  CAS  PubMed  Google Scholar 

  • Bedrosian I, Mick R, Xu S et al. (2003) Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol 21: 3826–3835

    Article  CAS  PubMed  Google Scholar 

  • Bendandi M, Gocke CD, Kobrin CB et al. (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [see comments]. Nat Med 5: 1171–1177

    CAS  PubMed  Google Scholar 

  • Bonini C, Ferrari G, Verzeletti S et al. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [see comments]. Science 276: 1719–1724

    Article  CAS  PubMed  Google Scholar 

  • Boon T, Coulie PG, Van den Eynde B (1997) Tumor antigens recognized by T cells. Immunol Today 18: 267–268

    Article  CAS  PubMed  Google Scholar 

  • Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M (1999) CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 93: 1992–2002

    CAS  PubMed  Google Scholar 

  • Caponigro F, Ionna F, Comella G (2004) New cytotoxic and molecular-targeted therapies of head and neck tumors. Curr Opin Oncol 16: 225–230

    Article  CAS  PubMed  Google Scholar 

  • Chang AE, Li Q, Jiang G et al. (2003) Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer. J Clin Oncol 21: 884–890

    Article  CAS  PubMed  Google Scholar 

  • Ciardiello F, De Vita F, Orditura M, Tortora G (2004) The role of EGFR inhibitors in nonsmall cell lung cancer. Curr Opin Oncol 16: 130–135

    CAS  PubMed  Google Scholar 

  • Cobleigh MA, Langmuir VK, Sledge GW et al. (2003) A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 30(Suppl 16): 117–124

    CAS  PubMed  Google Scholar 

  • Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550–1552

    CAS  PubMed  Google Scholar 

  • Dranoff G, Jaffee E, Lazenby A et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539–3543

    CAS  PubMed  Google Scholar 

  • Druker B, Talpaz M, Resta D et al. (2001) Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031–1037

    CAS  PubMed  Google Scholar 

  • Folkman J (1996) Tumor angiogenesis. Cancer medicine. Williams & Wilkins, Baltimore

    Google Scholar 

  • Guglielmi C, Arcese W, Dazzi F et al. (2002) Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 100: 397–405

    Article  CAS  PubMed  Google Scholar 

  • Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM (1994) Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261–3282

    CAS  PubMed  Google Scholar 

  • Herbst RS, Frankel SR (2004) Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer. Clin Cancer Res 10: 4245–4248

    Article  Google Scholar 

  • Hesdorffer C, Ayello J, Ward M et al. (1998) Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 16: 165–172

    CAS  PubMed  Google Scholar 

  • Hurwitz H, Fehrenbacher L, Novotny W et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342

    Article  CAS  PubMed  Google Scholar 

  • Jocham D, Richter A, Hoffmann L et al. (2004) Adjuvant autologous renal tumour cell vaccine and risk of tumor progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 363: 594–599

    CAS  PubMed  Google Scholar 

  • Johnson DH, Fehrenbacher L, Novotny WF et al. (2004) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small cell lung cancer. J Clin Oncol 22: 2184–2191

    CAS  PubMed  Google Scholar 

  • Keene JA, Forman J (1982) Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 155: 768–782

    Article  CAS  PubMed  Google Scholar 

  • King CA, Spellerberg MB, Zhu D et al. (1998) DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med 4: 1281–1286

    Article  CAS  PubMed  Google Scholar 

  • Kubal J, Wen SF, Leissner J et al. (2002) Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillations. J Clin Oncol 20: 957–965

    Google Scholar 

  • Nagayama H, Sato K, Morishita M et al. (2003) Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. Melanoma Res 13: 521–530

    CAS  PubMed  Google Scholar 

  • Nemunaitis J, Sterman D, Jablons D et al. (2004) Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. J Natl Cancer Inst 96: 326–331

    CAS  PubMed  Google Scholar 

  • Nestle FO, Alijagic S, Gilliet M et al. (1998) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 4: 328–332

    Article  CAS  PubMed  Google Scholar 

  • Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389–2401

    Article  CAS  PubMed  Google Scholar 

  • Romani N, Gruner S, Brang D et al. (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83–93

    Article  CAS  PubMed  Google Scholar 

  • Rudin CM, Kozloff M, Hoffman PC et al. (2004) Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small cell lung cancer. J Clin Oncol 22: 1110–1117

    Article  CAS  PubMed  Google Scholar 

  • Salgia R, Lynch T, Skarin A et al. (2003) Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol 21: 624–630

    Article  PubMed  Google Scholar 

  • Saltz LB, Meropol NJ, Loehrer PJ Sr et al. (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22: 1201–1208

    Article  CAS  PubMed  Google Scholar 

  • Schuler M, Herrmann R, De Greve JL et al. (2001) Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 19: 1750–1758

    CAS  PubMed  Google Scholar 

  • Soiffer R, Hodi FS, Haluska F et al. (2003) Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. J Clin Oncol 21: 3343–3350

    Article  CAS  PubMed  Google Scholar 

  • Stevenson FK, Zhu D, King CA, Ashworth LJ, Kumar S, Hawkins RE (1995) Idiotypic DNA vaccines against B-cell lymphoma. Immunol Rev 145: 211–228

    CAS  PubMed  Google Scholar 

  • Su Z, Dannull J, Heiser A et al. (2003) Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 63: 2127–2133

    CAS  PubMed  Google Scholar 

  • Swisher SG, Roth JA, Komaki R et al. (2003) Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9: 93–101

    CAS  PubMed  Google Scholar 

  • Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368–370

    CAS  PubMed  Google Scholar 

  • Trojan A, Schultze JL, Witzens M et al. (2000) Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med 6: 667–672

    CAS  PubMed  Google Scholar 

  • Vonderheide RH, Hahn WC, Schultze JL, Nadler LM (1999) The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10: 673–679

    Article  CAS  PubMed  Google Scholar 

  • Wendtner C-M, Kofler DM, Theiss HD et al. (2002) Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood 100: 1655–1661

    CAS  PubMed  Google Scholar 

  • Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ (2000) CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 96: 2917–2924

    CAS  PubMed  Google Scholar 

  • Yang JC, Haworth L, Sherry RM et al. (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349: 427–434

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Clemens-Martin Wendtner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Kurzeder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Kofler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Hallek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, D-93042, Regensburg

    Jürgen Schölmerich

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Wendtner, CM., Kurzeder, C., Kofler, D., Hallek, M. (2005). Experimentelle Therapie und somatische Gentherapie von Krebs. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_24

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation